MacroGenics
MGNX
#8365
Rank
S$0.37 B
Marketcap
S$5.87
Share price
5.09%
Change (1 day)
212.09%
Change (1 year)

MacroGenics (MGNX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$0.25 Billion

According to MacroGenics's latest financial reports the company's total liabilities are S$0.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

MacroGenics - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$0.25 B30.56%
2024-12-31S$0.19 B2.77%
2023-12-31S$0.19 B3.75%
2022-12-31S$0.18 B43.58%
2021-12-31S$0.12 B17.94%
2020-12-31S$0.10 B-0.69%
2019-12-31S$0.11 B-9.48%
2018-12-31S$0.12 B22.13%
2017-12-31S$99.83 M62.26%
2016-12-31S$61.52 M-5.3%
2015-12-31S$64.97 M-6.52%
2014-12-31S$69.5 M17.05%
2013-12-31S$59.38 M-21.66%
2012-12-31S$75.8 M-26.99%
2011-12-31S$0.10 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
S$151.44 B 59,497.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$110.31 B 43,310.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$107.64 B 42,261.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$42.43 B 16,601.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$106.92 B 41,976.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$85.75 B 33,648.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
S$0.28 B 12.48%๐Ÿ‡บ๐Ÿ‡ธ USA